专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4523011A Process for preparing 6-(substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds 失效
标题翻译：制备6-（取代苯基）-4,5-二氢-3（2H） - 哒嗪酮化合物的方法
公开(公告)号：US4523011A
公开(公告)日：1985-06-11
申请号：US594303
申请日：1984-03-28
申请人： Tsutomu Katakami , Nobuyuki Fukazawa , Hajime Iizuka , Takashi Nishina , Joji Kamiya , Yasuhito Tanaka , Takuo Nakano
发明人： Tsutomu Katakami , Nobuyuki Fukazawa , Hajime Iizuka , Takashi Nishina , Joji Kamiya , Yasuhito Tanaka , Takuo Nakano
IPC分类号： A61K31/50 , A61P7/02 , A61P9/12 , C07D237/04 , C07D401/12 , C07D403/12
CPC分类号： C07D401/12 , C07D237/04 , C07D403/12
摘要： 6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds possessing strong platelet aggregation inhibiting activity and blood pressure depressing activity, having the general formula: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl; R.sup.2 is hydrogen, lower alkyl, lower alkylthio or the grouping R.sup.5 --NH-- where R.sup.5 is lower alkyl; R.sup.3 is phenyl, pyridyl, benzyl, lower alkyl or a substituted phenyl group carrying at any desired position on the benzene ring thereof the grouping: ##STR2## where R.sup.1 has the same meaning as given above; R.sup.4 is hydrogen or halogen; n is 0 or 1; and when both R.sup.2 and R.sup.3 are lower alkyl groups, R.sup.2 and R.sup.3 may be combined together with the bridging member ##STR3## between them to form the structure: ##STR4## where m is 2 or 3, as well as physiologically acceptable acid-addition salts thereof, and processes for preparing them.

2. 发明授权

US5308848A Pyrimidinedione derivatives and antiarrythmic agents containing the same 失效
标题翻译：嘧啶二酮衍生物和含有它们的抗焦虑剂
公开(公告)号：US5308848A
公开(公告)日：1994-05-03
申请号：US927738
申请日：1992-08-12
申请人： Michihiko Miyamoto , Tsutomu Katakami , Nobuya Kawauchi , Tadahito Nobori , Joji Kamiya , Masaaki Ishii
发明人： Michihiko Miyamoto , Tsutomu Katakami , Nobuya Kawauchi , Tadahito Nobori , Joji Kamiya , Masaaki Ishii
IPC分类号： C07D239/54 , C07D239/545 , C07D401/12 , A61K31/505 , C07D239/10
CPC分类号： C07D239/545 , C07D401/12
摘要： A pyrimidinedione derivative compound has a basic backbone in which a phenyl group part and a pyrimidinedione part are linked by a linking structure comprising an alkyl chain containing two nitrogen atoms. This linking structure is represented by ##STR1## [wherein A is --(CH.sub.2).sub.n --, --CO-- or --O--(CH.sub.2).sub.m --; each of R.sup.1 and R.sup.2 is independently a hydrogen atom or a lower alkyl group which may be substituted by a hydroxyl group, or R.sup.1 and R.sup.2 may be so linked with each other as to make an alkylene chain and thus form a heterocyclic structure; R.sup.5 is a halogen atom, a hydroxyl group, a lower alkyloxycarbonyl group, a lower alkyloxy group which may be substituted by a lower alkyloxy group, or a lower alkyl group which may be substituted by a hydroxyl group, or R.sup.5 may be so linked with R.sup.1 as to make an alkylene chain and thus form a heterocyclic structure; n is 0, 1, 2 or 3 (when R.sup.5 is the hydroxyl group, n.noteq.0); m is 0, 1, 2 or 3; and k is 0, 1, 2 or 3 (however, a compound in which A is --O--(CH.sub.2).sub.m -- and R.sup.5 is the hydroxyl group is excluded from the pyrimidinedione derivative)]. The pyrimidinedione derivative and its acid addition salt are useful for a medical treatment of cardiac arrhythmias.
摘要翻译：嘧啶二酮衍生物化合物具有其中苯基部分和嘧啶二酮部分通过包含含有两个氮原子的烷基链的连接结构连接的碱性主链。该连接结构由表示，其中A是 - （CH 2）n - ， - CO-或-O-（CH 2）m - ; R 1和R 2各自独立地为氢原子或可以被羟基取代的低级烷基，或者R 1和R 2可以相互连接形成亚烷基链，从而形成杂环结构; R5是卤素原子，羟基，低级烷氧基羰基，可被低级烷氧基取代的低级烷氧基或可被羟基取代的低级烷基，或R5可以与 R1形成亚烷基链，从而形成杂环结构; n是0,1,2或3（当R5是羟基时，n是等于0）; m为0,1,2或3; 并且k为0,1,2或3（然而，其中A为-O-（CH 2）m - 且R 5为羟基的化合物不包括在嘧啶二酮衍生物中]]。嘧啶二酮衍生物及其酸加成盐可用于治疗心律失常。

3. 发明授权

US5192799A Coumaran group containing amine compounds and their acid addition salts and quaternary ammonium salts and the use thereof as anti arrhythmic agents and as psychotropic agents 失效
标题翻译：含有胺化合物的香豆素基团及其酸加成盐和季铵盐及其作为抗心律失常剂和作为精神药物的用途
公开(公告)号：US5192799A
公开(公告)日：1993-03-09
申请号：US895417
申请日：1992-06-05
申请人： Ikuo Tomino , Masaharu Ishiguro , Takumi Kitahara , Keiichi Yokoyama , Noriaki Kihara , Joji Kamiya , Kanji Yoshihara , Masaaki Ishii , Akira Mizuchi , Kazutoshi Horikomi , Akira Awaya , Takuo Nakano
发明人： Ikuo Tomino , Masaharu Ishiguro , Takumi Kitahara , Keiichi Yokoyama , Noriaki Kihara , Joji Kamiya , Kanji Yoshihara , Masaaki Ishii , Akira Mizuchi , Kazutoshi Horikomi , Akira Awaya , Takuo Nakano
IPC分类号： A61K31/34 , A61K31/35 , C07C217/18 , C07C217/22 , C07C217/32 , C07D209/08 , C07D209/48 , C07D211/14 , C07D215/04 , C07D217/02 , C07D217/24 , C07D235/06 , C07D265/36 , C07D307/78 , C07D307/79 , C07D307/80 , C07D307/83 , C07D307/86 , C07D307/91 , C07D311/04 , C07D311/08 , C07D311/14 , C07D311/16 , C07D311/18 , C07D311/20 , C07D311/22 , C07D311/24 , C07D311/58 , C07D311/74 , C07D317/06 , C07D317/46 , C07D317/48 , C07D327/04 , C07D401/12 , C07D405/12 , C07D407/12 , C07D471/10 , C07D487/04 , C07D487/22 , C07D491/10
CPC分类号： C07D209/48 , C07C217/18 , C07C217/22 , C07C217/32 , C07D209/08 , C07D211/14 , C07D215/04 , C07D217/02 , C07D217/24 , C07D235/06 , C07D265/36 , C07D307/78 , C07D307/79 , C07D307/80 , C07D307/83 , C07D307/86 , C07D307/91 , C07D311/04 , C07D311/14 , C07D311/16 , C07D311/18 , C07D311/20 , C07D311/22 , C07D311/24 , C07D311/58 , C07D317/46 , C07D317/48 , C07D327/04 , C07D401/12 , C07D405/12 , C07D407/12 , C07D471/10 , C07D487/04 , C07D491/10 , C07C2102/08
摘要： Amine represented by the following formula (1), or their acid addition salts or their quaternary ammonium salts. ##STR1## The amines of formula (1) or their pharmaceutically acceptable acid addition salts or quaternary ammonium salts are useful for the treatment and prevention of heart diseases of animals, particularly arrhythima, myocardial infarction, angina pectoris and heart failure and psychoneurological diseases.
摘要翻译：由下式（1）表示的胺或其酸加成盐或其季铵盐。（1）式（1）的胺或其药学上可接受的酸加成盐或季铵盐可用于治疗和预防动物的心脏病，特别是心律不齐，心肌梗塞，心绞痛和心力衰竭以及心理学疾病

4. 发明授权

US5008267A Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same 失效
标题翻译：嘧啶二酮化合物，其制备方法和含有它们的抗焦虑剂
公开(公告)号：US5008267A
公开(公告)日：1991-04-16
申请号：US425730
申请日：1989-10-24
申请人： Tsutomu Katakami , Tatsuro Yokoyama , Michihiko Miyamoto , Haruki Mori , Nobuya Kawauchi , Tadahito Nobori , Kunio Sannohe , Joji Kamiya , Masaaki Ishii , Kanji Yoshihara
发明人： Tsutomu Katakami , Tatsuro Yokoyama , Michihiko Miyamoto , Haruki Mori , Nobuya Kawauchi , Tadahito Nobori , Kunio Sannohe , Joji Kamiya , Masaaki Ishii , Kanji Yoshihara
IPC分类号： C07D239/54 , C07D239/545 , C07D401/12 , C07D403/12
CPC分类号： C07D239/545 , C07D401/12 , C07D403/12 , Y10S514/821
摘要： A pyrimidinedione derivative compound has a basic backbone in which a phenyl group part and a pyrimidinedione part are linked by a structure comprising an alkyl chain containing at least two nitrogen atoms. The pyrimidinedione derivative is useful for a medical treatment of cardiac arrhythmias.
摘要翻译：嘧啶二酮衍生物化合物具有碱性主链，其中苯基部分和嘧啶二酮部分通过包含至少两个氮原子的烷基链的结构连接。嘧啶二酮衍生物可用于治疗心律失常。

5. 发明授权

US4824952A Isoquinoline derivative 失效
标题翻译：异喹啉衍生物
公开(公告)号：US4824952A
公开(公告)日：1989-04-25
申请号：US754286
申请日：1985-07-12
申请人： Tsuneji Suzuki , Kunio Sannohe , Toshihiko Ito , Masahiko Maruyama , Joji Kamiya , Makoto Hirayama , Takafumi Kitano , Akira Awaya
发明人： Tsuneji Suzuki , Kunio Sannohe , Toshihiko Ito , Masahiko Maruyama , Joji Kamiya , Makoto Hirayama , Takafumi Kitano , Akira Awaya
IPC分类号： A61K31/47 , A61K31/472 , A61P9/04 , C07C45/45 , C07C49/403 , C07C49/517 , C07C49/657 , C07D213/50 , C07D217/26 , C07D401/04 , C07D405/04
CPC分类号： C07D401/04 , C07C45/455 , C07C49/403 , C07C49/517 , C07C49/657 , C07D213/50 , C07D217/26 , C07D405/04
摘要： An isoquinoline derivative of the following formula: ##STR1## wherein R.sub.1 is a methyl or a methoxymethyl group and R.sub.2 and R.sub.3 are each a hydrogen atom or a methyl, ethyl, methoxy, a cyclohexyl, a phenyl, a 3,4-dimethoxyphenyl, a pyridyl or an oxo (.dbd.O) group;and therapeutically acceptable salts thereof which exhibit a low toxicity and a wide range of safety and are highly useful as a cardiotonic medication.
摘要翻译：下式的异喹啉衍生物：其中R 1是甲基或甲氧基甲基，R 2和R 3各自为氢原子或甲基，乙基，甲氧基，环己基，苯基，3,4 吡啶基或氧代（= O）基团; 和其治疗上可接受的盐，其表现出低毒性和广泛的安全性，并且作为强心药物是非常有用的。

6. 发明授权

US5332739A Pyrimidinedione derivatives and antiarrhythmic agents containing same 失效
标题翻译：嘧啶二酮衍生物和含有它们的抗心律失常药
公开(公告)号：US5332739A
公开(公告)日：1994-07-26
申请号：US971059
申请日：1992-11-02
申请人： Tsutomu Katakami , Tatsuro Yokoyama , Michihiko Miyamoto , Haruki Mori , Nobuya Kawauchi , Tadahito Nobori , Joji Kamiya , Masaaki Ishii
发明人： Tsutomu Katakami , Tatsuro Yokoyama , Michihiko Miyamoto , Haruki Mori , Nobuya Kawauchi , Tadahito Nobori , Joji Kamiya , Masaaki Ishii
IPC分类号： C07D239/54 , A61K31/505 , A61P9/00 , A61P9/06 , C07D239/545 , C07D401/12 , C07D403/12 , C07D405/12 , A61K31/50 , C07D239/42 , C07D403/04
CPC分类号： C07D239/545 , C07D401/12
摘要： Pyrimidinedione derivatives of the formula: ##STR1## wherein R.sup.1 and R.sup.2 is so linked with each other as to make an alkylene chain and thus form a heterocyclic structure, A, R.sup.3, R.sup.4, X.sup.1, X.sup.2 and X.sup.3 are substituents, respectively, and n is 2 or 3 have a basic backbone in which a phenyl group part and a pyrimidinedione part are linked by a structure comprising an alkyl chain and a heterocyclic ring having two nitrogen atoms. These compounds are useful for a medical treatment of cardiac arrhythmias.
摘要翻译：其中R1和R2彼此连接以形成亚烷基链，从而形成杂环结构，其中A，R 3，R 4，X 1，X 2和X 3分别是取代基，并且n 2或3具有其中苯基部分和嘧啶二酮部分通过包含烷基链和具有两个氮原子的杂环的结构连接的基本主链。这些化合物可用于治疗心律失常。

7. 发明授权

US5114941A Pyrimidinedione derivative compounds, method for preparing same, and antiarrythmic agents containing same 失效
标题翻译：吡啶衍生物衍生化合物，其制备方法和含有其的抗菌剂
公开(公告)号：US5114941A
公开(公告)日：1992-05-19
申请号：US618245
申请日：1990-11-27
申请人： Tsutomu Katakami , Tatsuro Yokoyama , Haruki Mori , Nobuya Kawauchi , Joji Kamiya , Masaaki Ishii
发明人： Tsutomu Katakami , Tatsuro Yokoyama , Haruki Mori , Nobuya Kawauchi , Joji Kamiya , Masaaki Ishii
IPC分类号： A61K31/505 , A61P9/06 , C07D405/12 , C07D405/14
CPC分类号： C07D405/12
摘要： A pyrimidinedione derivative compound has a basic backbone in which a 4-oxobenzopyran ring group part and a pyrimidinedione part are linked by a structure comprising an alkyl chain containing at least two nitrogen atoms and one oxygen. The pyrimidinedione derivative is useful for a medical treatment of cardiac arrhythmias.

8. 发明授权

US4845228A Pyridyl-cyclohexanone compounds 失效
标题翻译：吡啶基 - 环己酮化合物
公开(公告)号：US4845228A
公开(公告)日：1989-07-04
申请号：US148630
申请日：1988-01-26
申请人： Tsuneji Suzuki , Sannohe, Kunio , Toshihiko Ito , Masahiko Maruyama , Joji Kamiya , Makoto Hirayama , Takafumi Kitano , Akira Awaya
发明人： Tsuneji Suzuki , Sannohe, Kunio , Toshihiko Ito , Masahiko Maruyama , Joji Kamiya , Makoto Hirayama , Takafumi Kitano , Akira Awaya
IPC分类号： A61K31/47 , A61K31/472 , A61P9/04 , C07C45/45 , C07C49/403 , C07C49/517 , C07C49/657 , C07D213/50 , C07D217/26 , C07D401/04 , C07D405/04
CPC分类号： C07D401/04 , C07C45/455 , C07C49/403 , C07C49/517 , C07C49/657 , C07D213/50 , C07D217/26 , C07D405/04
摘要： The present invention relates to cyclohexanone derivatives represented by general formula: ##STR1## wherein R represents a hydrogen atom or an acetyl group. The cyclohexanone derivatives are important intermediates for producing isoquinoline derivatives which are useful as drugs, especially for heart drugs.
摘要翻译：本发明涉及由通式：（A）表示的环己酮衍生物，其中R表示氢原子或乙酰基。环己酮衍生物是生产异喹啉衍生物的重要中间体，其可用作药物，特别是用于心脏药物。

9. 发明授权

US4639451A Pyridazinone derivatives 失效
标题翻译：哒嗪酮衍生物
公开(公告)号：US4639451A
公开(公告)日：1987-01-27
申请号：US504039
申请日：1983-06-03
申请人： Tsutomu Katakami , Nobuyuki Fukazawa , Hajime Iizuka , Takashi Nishina , Joji Kamiya , Yasuhito Tanaka , Takuo Nakano
发明人： Tsutomu Katakami , Nobuyuki Fukazawa , Hajime Iizuka , Takashi Nishina , Joji Kamiya , Yasuhito Tanaka , Takuo Nakano
IPC分类号： C07D237/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , A61K31/50
CPC分类号： C07D401/12 , C07D237/04 , C07D403/12 , C07D405/12 , C07D409/12
摘要： This invention relates to pyridazinone derivatives of the general formula: ##STR1## [wherein R.sup.1 stands for a hydrogen atom or a lower alkyl group; R.sup.2 for a hydrogen atom or a lower alkyl group; and A for (i) a ring selected from a benzene ring, a furan ring, a thiophene ring and a pyridine ring (on which ring 1-3 substituents or atoms selected from amino groups, nitro groups, lower alkanoylamino groups, hydroxyl groups, lower alkanoyloxy groups, sulfamoyl groups and halogen atoms may be present), or (ii) a grouping of the formula: ##STR2## (wherein R.sup.3 stands for a hydrogen atom, a lower alkyl group, a phenyl(lower)alkyl, a hydroxyphenyl(lower)alkyl group, a lower alkylmercapto(lower)alkyl group, a benzylmercapto(lower)alkyl group, a guanidino(lower)alkyl group, a nitroguanidino(lower)alkyl group, an indolyl(lower)alkyl group, a carbamoyl(lower)alkyl group or a carboxy(lower)alkyl group, R.sup.4 for a hydrogen atom or a lower alkyl group, R.sup.5 for a hydrogen atom, a lower alkyl group, a lower alkanoyl group, a benzoyl or a benzyloxycarbonyl group, and R.sup.3 and R.sup.4 may be combined to form a grouping of the formula: ##STR3## which forms a ring), or (iii) a grouping of the formula: ##STR4## (wherein R.sup.6, R.sup.7 and R.sup.8 each stand for a hydrogen atom or a lower alkyl group, B is an oxygen atom or a sulfur atom, R.sup.9 stands for a hydrogen atom or a lower alkanoyl group, and n is 0 or 1)].
摘要翻译： PCT No.PCT / JP82 / 00415 Sec。 371日期：1983年6月3日 102（e）日期1983年6月3日PCT提交1982年10月20日PCT公布。第WO83 / 01447号公报日本1983年4月28日。本发明涉及以下通式的哒嗪酮衍生物：其中R1代表氢原子或低级烷基; R2为氢原子或低级烷基; A为（i）选自苯环，呋喃环，噻吩环和吡啶环的环（其中1-3个取代基或选自氨基，硝基，低级烷酰基氨基，羟基，低级烷酰氧基，氨磺酰基和卤素原子可以存在），或（ii）下式的基团：其中R3代表氢原子，低级烷基，苯基（低级）烷基，羟基苯基（低级）烷基，低级烷基巯基（低级）烷基，苄基巯基（低级）烷基，胍基（低级）烷基，硝基胍基（低级）烷基，吲哚基（低级）烷基，氨基甲酰基低级）烷基或羧基（低级）烷基，R4表示氢原子或低级烷基，R5表示氢原子，低级烷基，低级链烷酰基，苯甲酰基或苄氧基羰基，R3和 R4可以组合以形成下式的分组：形成环的），或（iii）下式的分组：（其中R6，R7和R8各自代表氢原子或低级烷基，B是氧原子或硫原子，R9代表氢原子或低级烷酰基，n是0或1）]。

10. 发明授权

US4521415A 6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds 失效
标题翻译：（取代的苯基）-4,5-二氢-3（2H） - 哒嗪酮化合物
公开(公告)号：US4521415A
公开(公告)日：1985-06-04
申请号：US454021
申请日：1982-12-28
申请人： Tsutomu Katakami , Nobuyuki Fukazawa , Hajime Iizuka , Takashi Nishina , Joji Kamiya , Yasuhito Tanaka , Takuo Nakano
发明人： Tsutomu Katakami , Nobuyuki Fukazawa , Hajime Iizuka , Takashi Nishina , Joji Kamiya , Yasuhito Tanaka , Takuo Nakano
IPC分类号： A61K31/50 , A61P7/02 , A61P9/12 , C07D237/04 , C07D401/12 , C07D403/12
CPC分类号： C07D401/12 , C07D237/04 , C07D403/12
摘要： 6-(Substituted phenyl)-4,5-dihydro-3(2H)-pyridazinone compounds possessing strong platelet aggregation inhibiting activity and blood pressure depressing activity, having the general formula: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl; R.sup.2 is hydrogen, lower alkyl, lower alkylthio or the grouping R.sup.5 --NH-- where R.sup.5 is lower alkyl; R.sup.3 is phenyl, pyridyl, benzyl, lower alkyl or a substituted phenyl group carrying at any desired position on the benzene ring thereof the grouping: ##STR2## where R.sup.1 has the same meaning as given above; R.sup.4 is hydrogen or halogen; n is 0 or 1; and when both R.sup.2 and R.sup.3 are lower alkyl groups, R.sup.2 and R.sup.3 may be combined together with the bridging member ##STR3## where m is 2 or 3, as well as physiologically acceptable acid-addition salts thereof, and processes for preparing them.
摘要翻译：具有强烈的血小板聚集抑制活性和降低血压的6-（取代的苯基）-4,5-二氢-3（2H） - 哒嗪酮化合物，具有以下通式：其中R 1为氢或低级烷基 ; R2是氢，低级烷基，低级烷硫基或分组R5-NH-，其中R5是低级烷基; R3是苯基，吡啶基，苄基，低级烷基或在其苯环上的任何所需位置携带的取代苯基，其分子式如下：其中R 1具有与上述相同的含义; R4是氢或卤素; n为0或1; 当R 2和R 3均为低级烷基时，R 2和R 3可以与m为2或3的桥连基团以及其生理上可接受的酸加成盐组合在一起，以及制备方法他们。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式